Takeda receives positive CHMP opinion in Europe for EdarbiTM (azilsartan medoxomil)
29 September 2011 | By Takeda Pharmaceutical Company Limited
The CHMP has issued a positive opinion for EdarbiTM (azilsartan medoxomil)...
List view / Grid view
29 September 2011 | By Takeda Pharmaceutical Company Limited
The CHMP has issued a positive opinion for EdarbiTM (azilsartan medoxomil)...
27 September 2011 | By kdm communications limited
Tecan has launched a new generation of high quality MCA 384 Disposable Tips...
27 September 2011 | By Boehringer Ingelheim
Results from a Phase I/II study...
27 September 2011 | By Novartis
Novartis has received regulatory approval in Japan for once-daily Gilenya (fingolimod)...
27 September 2011 | By Novartis
Novartis has presented new Phase III data at the ERS congress...
26 September 2011 | By Buchi
The Encapsulator B-390 & B-395 Pro, are designed for the immobilization of enzymes, drugs...
26 September 2011 | By Boehringer Ingelheim
Boehringer Ingelheim will establish a new separate business for the development and commercialization of own biosimilars...
26 September 2011 | By The Scott Partnership
Field Flow Fractionation (FFF) technology announced...
26 September 2011 | By Eli Lilly and Company
New data from PARAMOUNT study shows benefit in this hard-to-treat population...
26 September 2011 | By Novartis
Afinitor® more than doubled the time women lived without tumor growth...
26 September 2011 | By Eli Lilly and Company
CHMP has issued a positive opinion for the use of ALIMTA® as continuation maintenance therapy for deadly form of lung cancer...
26 September 2011 | By AstraZeneca
AstraZeneca announced that FASLODEX™ (fulvestrant) has received regulatory approval...
25 September 2011 | By Roche
Phase II study TDM4450g results announced...
23 September 2011 | By AstraZeneca
KOMBOGLYZE™ receives a positive opinion from CHMP...
23 September 2011 | By Novartis
The CHMP adopted a positive opinion for Rasitrio® for the treatment of high blood pressure...